Abstract |
Long-term exposure to arsenic induces arsenical cancers in human beings. Arsenic has been shown to induce apoptosis in a variety of cell systems. Previous studies revealed that patients with arsenic-induced Bowen's disease showed a defective cell-mediated immunity and decreased percentages of T cell and T helper cell subpopulations in peripheral mononuclear cells. The purpose of this study was to investigate the effects of arsenic on T cell survival and function in mononuclear cells. Arsenic concentrations higher than 1 micro M induced tumor necrosis factor alpha release from mononuclear cells and caused a cytotoxic effect on T cells. When exposed to higher concentrations of arsenic, apoptosis was induced. CD4+ cells were the major apoptoic population in mononuclear cells. Tumor necrosis factor receptor 1 expression on CD4+ cells, but not Fas/FasL, was significantly enhanced by arsenic treatment compared to other mononuclear cells. Increased expressions of tumor necrosis factor receptor 1 related death domain proteins and activated caspases were observed. These findings indicate that tumor necrosis factor receptor 1 signaling is the major pathway in arsenic-induced T helper cell apoptosis.
|
Authors | Hsin-Su Yu, Wei-Ting Liao, Kee-Lung Chang, Chia-Li Yu, Gwo-Shing Chen |
Journal | The Journal of investigative dermatology
(J Invest Dermatol)
Vol. 119
Issue 4
Pg. 812-9
(Oct 2002)
ISSN: 0022-202X [Print] United States |
PMID | 12406325
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antigens, CD
- Receptors, Tumor Necrosis Factor
- Receptors, Tumor Necrosis Factor, Type I
- Tumor Necrosis Factor-alpha
- Interferon-gamma
- Arsenic
|
Topics |
- Adult
- Antigens, CD
(analysis, physiology)
- Apoptosis
(drug effects)
- Arsenic
(toxicity)
- CD4-Positive T-Lymphocytes
(drug effects, physiology)
- Humans
- Interferon-gamma
(biosynthesis)
- Leukocytes, Mononuclear
(drug effects, physiology)
- Receptors, Tumor Necrosis Factor
(analysis, physiology)
- Receptors, Tumor Necrosis Factor, Type I
- Tumor Necrosis Factor-alpha
(biosynthesis)
|